Thank you.
In terms of this study, to my mind the question of the frequency of the adverse drug reaction remains. This issue of quantity versus quality, and why both couldn't be considered relevant, has been on my mind since we've started our study. Obviously everyone agrees that we're trying to maximize the knowledge and the reporting in general, and of course the quality, so does it not matter how often it would happen?